Thus, our study establishes dNTP insufficiency in the mitochondria as the cause of mitochondrial DNA depletion in MPV17 deficiency, and identifies deoxynucleoside supplementation as a potential therapeutic strategy for MPV17-related disease. The gene discussed is MPV17; the disease is hyperinsulinemic hypoglycemia, familial, 4.